entertainment -WSS

entertainment

author：comprehensive 2025-09-30 00:36:05 - browse：723

Photograph of a person wearing blue gloves counts money. -- health business coverage from STAT — Adobe

WASHINGTON — Doctors are staring down a cut to their Medicare pay next year, and while the news has united them in outrage, it’s also turned one specialty against another.

Medicare officials last week announced its major annual update to the way the program pays physicians. Along with other changes, it includes a policy that will boost payments to specialties that rely on evaluating and managing patients, as opposed to those that focus on procedures. But in Medicare, boosting payments in one area almost always means cutting them somewhere else. So to pay for that, doctors across the country will see a roughly 3% cut to a factor that determines how much Medicare pays them for caring for seniors.

The change has pitted certain specialties against primary care doctors. A host of surgeons’ groups, including the American College of Surgeons, plainly criticized family physicians in a recent letter to Medicare, saying there’s no “valid justification” for the boost and calling it an “inappropriate” overpayment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： CDC concerned about possible undetected monkeypox spread in U.K.

hotspot

WSS

Driven by the pandemic, applicants flood public health schools

Paxlovid study fails to answer questions over benefit for broader groups

Disclosing genetic information: not as worrisome as once feared

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

EF3 tornado rips through North Carolina amid extreme weather nationwide

Do masks work? RCTs can't tell us

leisure time

entertainment

focus

Medicare details structure of new drug price negotiation program

Texas Department of Public Safety speaks out on migrant abuse allegations

Duchenne breakthrough therapy leaves behind pioneering families

Tocagen's brain cancer gene therapy trial continues. Investors worry

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Tocagen's brain cancer gene therapy trial continues. Investors worry

George Santos makes 1st court appearance after pleading not guilty to 13 counts

DeSantis talks Trump, trans issues and 'what wokeness is'

Guidelines to prevent youth baseball injuries need more muscle

Tesla recalling nearly 16,000 of its 2021

leisure time

Awakening the world to the whoosh: A patient's crusade

The science behind Janet Jackson's pregnancy at 49

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Why Congress must ban federal programs from using QALYs

Vir antibody drug aimed at influenza A fails in clinical trial

The story of mRNA: From a loose idea to a tool that may help curb Covid

hotspot

hotspot

explore

focus